May 6, 2020 / 8:54 PM / a month ago

BRIEF-Enanta Pharmaceuticals Posts Q2 Loss Per Share Of $0.30

May 6 (Reuters) - Enanta Pharmaceuticals Inc:

* Q2 LOSS PER SHARE $0.30

* Q2 EARNINGS PER SHARE ESTIMATE $-0.89 — REFINITIV IBES DATA

* ENANTA PHARMACEUTICALS - ON TRACK TO INITIATE PHASE 1B STUDY OF EDP-514 IN VIREMIC HEPATITIS B PATIENTS IN 2Q 2020 AND PHASE 1 STUDY OF EDP-297 IN 3Q

* ROYALTY REVENUE FOR QUARTER WAS $27.6 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below